Registered Executive Gang Cheol-jung Acquires 2,000 Shares of NEXTBIOMEDICAL via Open Market Purchase

Executive Director Gang Cheol-jung acquired 2,000 common shares of NEXTBIOMEDICAL at 40,650 KRW per share through an open market purchase on June 18, 2026.
This acquisition slightly increases his stake to 0.02%, a negligible level compared to the company's total outstanding shares of 8,277,286.
As a voluntary insider purchase, it does not affect the company's capital structure, funding, or shareholder dilution, and poses no governance risk.
[AI Summary]A routine insider purchase with no capital changes or corporate purpose, thus neutral. The impact on stock price or governance is minimal, and it does not introduce any significant risk for shareholders.